The present disclosure relates generally to thrombectomy devices. An exemplary catheter comprises: a central tube; an emitter assembly mounted over the central tube, wherein the emitter assembly comprises: a conductive sheath; a first insulated wire having a first curved distal portion; and a second insulated wire having a second curved distal portion, wherein the first curved distal portion and the second curved distal portion are positioned within the conductive sheath, and wherein the emitter assembly is configured to generate a plurality of cavitation bubbles or shockwaves when a pulsed voltage is applied to the emitter assembly; and an outer tube housing the emitter assembly, wherein the outer tube is configured to receive a conductive fluid, wherein the outer tube comprises a distal opening for releasing the plurality of cavitation bubbles or shockwaves and the conductive fluid in a forward direction to treat thrombus at a treatment site.

Devices, systems and methods are provided for stabilizing and grasping tissues such as valve leaflets, assessing the grasp of these tissues, approximating and fixating the tissues, and assessing the fixation of the tissues to treat cardiac valve regurgitation, particularly mitral valve regurgitation.

A method of making an ultrasonic catheter, disposing an ultrasound member in the main lumen of a flexible catheter body; providing an intermediate member and a tip, wherein at least a tip maximum-diameter portion is disposed in the intermediate member, wherein an intermediate-member outer diameter substantially matches a main lumen inner diameter, and wherein a tip distal cross-section has a tip distal cross-section area less than a tip proximal cross-section area of a tip proximal cross-section; and attaching the intermediate member to the catheter body and to the tip, wherein at least one of the tip and the intermediate member is configured to prevent separation of the tip of the ultrasound member from the catheter body.

A method may include producing, in a solution, microbubbles of nitric oxide having a targeted size; and directing the solution to a right side of a patient's heart, such that the microbubbles are directed to the patient's pulmonary arteries prior to being circulated through the patient's body. The solution may include saline or dextrose. Directing the solution to the right side of the patient's heart may include delivering the solution via a catheter, during a right-heart catheterization procedure. Directing the solution to the right side of the patient's heart may include injecting the solution into a median cubital vein of the patient. Directing the solution to the right side of the patient's heart comprises injecting the solution into an internal jugular vein, an external jugular vein or a femoral vein of the patient. The targeted size may correspond to a diameter of a specific branch of the patient's pulmonary arteries.

In one embodiment of the present invention, a system for treating an occlusion within a patient's vasculature with ultrasonic energy comprises a catheter configured to be passed through the patient's vasculature such that a portion of the catheter is positioned at an intravascular treatment site. The system further comprises an ultrasound radiating member, an ultrasound signal generator configured to supply a drive signal to the ultrasound radiating member, an infusion pump configured to pump a therapeutic compound into the fluid delivery lumen so as to cause the therapeutic compound to be delivered to the treatment site and a controller configured to control the ultrasound signal generator and the infusion pump.

A method for treating a treatment site (106) within or adjacent to a heart valve (108) within a body of a patient includes the steps of generating energy with an energy source (124); receiving energy from the energy source (124) with an energy guide (122A); positioning a balloon assembly (104) adjacent to the treatment site (106), the balloon assembly (104) including an outer balloon (104B) and an inner balloon (104A) that is positioned within and at least partially spaced-apart from the outer balloon (104B) to define an interstitial space (146A) therebetween that is configured to retain a balloon fluid (132); and positioning a portion of the energy guide (122A) that receives the energy from the energy source (124) within the interstitial space (146A) between the balloons (104A, 104B) so that a plasma-induced bubble (134) is formed in the balloon fluid (132) within the interstitial space (146A).

A treatment system for debriding a treatment area of a tissue site and applying negative pressure is disclosed. In some embodiments, the treatment system may include an ultrasonic bubble generator fluidly coupled to a negative-pressure source, fluid source, and a dressing. Fluid may be drawn from the fluid source to the ultrasonic bubble generator, whereby micro-bubbles and ultrasonic waves may be generated in the fluid before the fluid is instilled to the dressing.

Methods for performing non-invasive thrombolysis with ultrasound using, in some embodiments, one or more ultrasound transducers to focus or place a high intensity ultrasound beam onto a blood clot (thrombus) or other vascular inclusion or occlusion (e.g., clot in the dialysis graft, deep vein thrombosis, superficial vein thrombosis, arterial embolus, bypass graft thrombosis or embolization, pulmonary embolus) which would be ablated (eroded, mechanically fractionated, liquefied, or dissolved) by ultrasound energy. The process can employ one or more mechanisms, such as of cavitational, sonochemical, mechanical fractionation, or thermal processes depending on the acoustic parameters selected. This general process, including the examples of application set forth herein, is henceforth referred to as “Thrombolysis.”

Devices, systems and methods are provided for stabilizing and grasping tissues such as valve leaflets, assessing the grasp of these tissues, approximating and fixating the tissues, and assessing the fixation of the tissues to treat cardiac valve regurgitation, particularly mitral valve regurgitation.

An ultrasonic catheter has a flexible catheter body having a main lumen, a catheter body interior wall, and a catheter body open distal end. The ultrasonic catheter has an ultrasound transmission member disposed in the main lumen. The ultrasonic catheter has a distal tip that is disposed on the ultrasound transmission member distal end. The ultrasonic catheter includes an intermediate member having an intermediate member open proximal end, an intermediate member open distal end, and an intermediate member interior wall forming a hollow interior. The intermediate member is attached to the catheter body interior wall at the catheter body open distal end. The hollow interior has a smallest inner diameter adjacent the intermediate member open proximal end. The hollow interior configured to overlap the ultrasound transmission member distal end and at least a portion of the distal tip.